Joseph Gilliam
Board Member
10x Genomics, Inc. (TXG)Equibles does not estimate personal net worth.
Get an email with a short summary when 10x Genomics, Inc. publishes a filing, an earnings call transcript or a press release.
Get TXG alertsAbout Joseph Gilliam
Joseph Gilliam is recorded as Board Member at 10x Genomics, Inc. (TXG) since October 28, 2026. 10x Genomics, Inc. reported in an 8-K filed November 2, 2026 that Joseph Gilliam was appointed Class III director, effective October 28, 2026. 10x Genomics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at 10x Genomics, Inc. includes Serge Saxonov (CEO and Board Member), John R. Stuelpnagel (Chairman and Board Member), Mr. Gilliam (Chairman) and 7 others.
“On October 28, 2026, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of Directors of 10x Genomics, Inc. (the “Company”) appointed Ansuman Satpathy and Joseph Gilliam to the Board of Directors as Class III directors effective immediately, each with a term expiring at the Company's 2028 annual meeting of stockholders or until his successor is duly elected and qualified or until his earlier death, resignation, disqualification or removal.”
Affiliation history
-
Current
2026-10-28–present
Company network
Leadership on record at 10x Genomics, Inc.
- Serge Saxonov CEO, Board Member
- John R. Stuelpnagel Chairman, Board Member
- Mr. Gilliam Chairman
- Adam S. Taich CFO
- Randy Wu General Counsel
- Alan Mateo Board Member
- Alan V. Mateo Board Member
- Ansuman Satpathy Board Member
- Benjamin J. Hindson Board Member
- Kimberly J. Popovits Board Member